Allena Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ALNA Allena Pharmaceuticals Inc
KLAC KLA Corp
CNVY Convey Health Solutions Holdings Inc
EBAY eBay Inc
PRLX Parallax Health Sciences Inc
AXS AXIS Capital Holdings Ltd
SPNS Sapiens International Corporation NV
SPCE Virgin Galactic Holdings Inc
BBLG Bone Biologics Corp
RPT RPT Realty
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Allena Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. The Company is focused on metabolic disorders that result in excess accumulation of certain metabolites that can cause kidney stones, damage the kidney, and potentially lead to chronic kidney disease (CKD) and end-stage renal disease (ESRD). The Company’s lead product candidate, reloxaliase, is an oral enzyme therapeutic developing for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate (UOx) levels and commonly associated with kidney stones, CKD and ESRD. Its second product candidate, ALLN-346, is an orally administered, novel, urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced CKD. The Company is conducting two Phase IIa studies for ALLN-346.

Closing Price
$0.1279
Day's Change
-0.0091 (-6.64%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.137
Day's Low
0.12
Volume
(Light)
Volume:
8,892,234

10-day average volume:
23,286,753
8,892,234
  • Prev Close
    0.137
  • Today's Open
    0.1341
  • Day's Range
    0.12-0.137
  • Avg Vol (10-day)
    23.3M
  • Last (time)
    4:00p ET 08/09/22
  • Last (size)
    2.9K
  • 52-Wk Range
    0.0683 - 1.17
    LowHigh
  • (11/03/21 - 05/11/22)
    87.26%
  • 153.0%
  • Market Cap
    13.8M
  • Shares Outstanding
    107.7M
  • -0.67
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 7.50
  • (% of float 07/15/22)
    8.07

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.